DK1748043T3 - Polysubstituerede 1,1-pyridinyloxycyclopropanaminderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse - Google Patents
Polysubstituerede 1,1-pyridinyloxycyclopropanaminderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disseInfo
- Publication number
- DK1748043T3 DK1748043T3 DK06291219T DK06291219T DK1748043T3 DK 1748043 T3 DK1748043 T3 DK 1748043T3 DK 06291219 T DK06291219 T DK 06291219T DK 06291219 T DK06291219 T DK 06291219T DK 1748043 T3 DK1748043 T3 DK 1748043T3
- Authority
- DK
- Denmark
- Prior art keywords
- pyridinyloxycyclopropanamine
- polysubstituted
- derivatives
- preparation
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0508033A FR2889187B1 (fr) | 2005-07-28 | 2005-07-28 | Nouveaux composes 1,1-pyridinyloxycyclopropanamines polysusbstitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1748043T3 true DK1748043T3 (da) | 2008-12-08 |
Family
ID=35841768
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK06291219T DK1748043T3 (da) | 2005-07-28 | 2006-07-27 | Polysubstituerede 1,1-pyridinyloxycyclopropanaminderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US7348344B2 (pt) |
| EP (1) | EP1748043B1 (pt) |
| JP (1) | JP2007077135A (pt) |
| KR (1) | KR100824830B1 (pt) |
| CN (1) | CN100519531C (pt) |
| AR (1) | AR054875A1 (pt) |
| AT (1) | ATE405550T1 (pt) |
| AU (1) | AU2006203241A1 (pt) |
| BR (1) | BRPI0603064A (pt) |
| CA (1) | CA2552827A1 (pt) |
| DE (1) | DE602006002328D1 (pt) |
| DK (1) | DK1748043T3 (pt) |
| EA (1) | EA011126B1 (pt) |
| ES (1) | ES2313589T3 (pt) |
| FR (1) | FR2889187B1 (pt) |
| GE (1) | GEP20084548B (pt) |
| HR (1) | HRP20080536T5 (pt) |
| MA (1) | MA28426B1 (pt) |
| MX (1) | MXPA06008415A (pt) |
| NO (1) | NO20063461L (pt) |
| NZ (1) | NZ548747A (pt) |
| PL (1) | PL1748043T3 (pt) |
| PT (1) | PT1748043E (pt) |
| SG (1) | SG129411A1 (pt) |
| SI (1) | SI1748043T1 (pt) |
| WO (1) | WO2007012762A1 (pt) |
| ZA (1) | ZA200606277B (pt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2896800B1 (fr) * | 2006-01-30 | 2008-04-11 | Servier Lab | Nouveaux composes pyridinylaminoalkylene-et pyridinyloxyalkylene-cyclopropanamines polysubstitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| HUE033352T2 (en) * | 2009-11-18 | 2017-11-28 | Suven Life Sciences Ltd | Bicyclic compounds as alpha4-beta2 nicotinic acetylcholine receptor ligands |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2095350C1 (ru) * | 1993-10-13 | 1997-11-10 | Центр по химии лекарственных средств (ЦХЛС-ВНИХФИ) | 3-(n,n-диметилкарбамоилокси)-2-этил-6-метилпиридина сукцинат, обладающий антигипоксической активностью |
| TW544448B (en) * | 1997-07-11 | 2003-08-01 | Novartis Ag | Pyridine derivatives |
| FR2810664B1 (fr) * | 2000-06-27 | 2004-12-24 | Adir | Nouveaux composes cyclopropaniques 1,1 et 1,2-dissubstitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
-
2005
- 2005-07-28 FR FR0508033A patent/FR2889187B1/fr not_active Expired - Fee Related
-
2006
- 2006-07-10 MA MA29177A patent/MA28426B1/fr unknown
- 2006-07-20 CA CA002552827A patent/CA2552827A1/fr not_active Abandoned
- 2006-07-21 SG SG200604914A patent/SG129411A1/en unknown
- 2006-07-26 MX MXPA06008415A patent/MXPA06008415A/es active IP Right Grant
- 2006-07-26 NZ NZ548747A patent/NZ548747A/en unknown
- 2006-07-26 US US11/493,070 patent/US7348344B2/en not_active Expired - Fee Related
- 2006-07-27 NO NO20063461A patent/NO20063461L/no not_active Application Discontinuation
- 2006-07-27 DK DK06291219T patent/DK1748043T3/da active
- 2006-07-27 GE GEAP20069543A patent/GEP20084548B/en unknown
- 2006-07-27 WO PCT/FR2006/001832 patent/WO2007012762A1/fr active Application Filing
- 2006-07-27 SI SI200630083T patent/SI1748043T1/sl unknown
- 2006-07-27 KR KR1020060070569A patent/KR100824830B1/ko not_active IP Right Cessation
- 2006-07-27 DE DE602006002328T patent/DE602006002328D1/de not_active Expired - Fee Related
- 2006-07-27 AR ARP060103249A patent/AR054875A1/es unknown
- 2006-07-27 EA EA200601248A patent/EA011126B1/ru not_active IP Right Cessation
- 2006-07-27 ES ES06291219T patent/ES2313589T3/es active Active
- 2006-07-27 EP EP06291219A patent/EP1748043B1/fr active Active
- 2006-07-27 PT PT06291219T patent/PT1748043E/pt unknown
- 2006-07-27 PL PL06291219T patent/PL1748043T3/pl unknown
- 2006-07-27 AT AT06291219T patent/ATE405550T1/de not_active IP Right Cessation
- 2006-07-28 ZA ZA200606277A patent/ZA200606277B/xx unknown
- 2006-07-28 JP JP2006206041A patent/JP2007077135A/ja active Pending
- 2006-07-28 AU AU2006203241A patent/AU2006203241A1/en not_active Abandoned
- 2006-07-28 BR BRPI0603064-5A patent/BRPI0603064A/pt not_active IP Right Cessation
- 2006-07-28 CN CNB2006101089323A patent/CN100519531C/zh not_active Expired - Fee Related
-
2008
- 2008-11-19 HR HR20080536T patent/HRP20080536T5/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GEP20084548B (en) | 2008-11-25 |
| PL1748043T3 (pl) | 2008-12-31 |
| CN100519531C (zh) | 2009-07-29 |
| SG129411A1 (en) | 2007-02-26 |
| US20070027191A1 (en) | 2007-02-01 |
| FR2889187A1 (fr) | 2007-02-02 |
| CA2552827A1 (fr) | 2007-01-28 |
| BRPI0603064A (pt) | 2007-08-14 |
| HRP20080536T5 (en) | 2009-03-31 |
| WO2007012762A1 (fr) | 2007-02-01 |
| FR2889187B1 (fr) | 2007-09-07 |
| US7348344B2 (en) | 2008-03-25 |
| HRP20080536T3 (en) | 2009-02-28 |
| EP1748043A1 (fr) | 2007-01-31 |
| ES2313589T3 (es) | 2009-03-01 |
| ZA200606277B (en) | 2007-04-25 |
| ATE405550T1 (de) | 2008-09-15 |
| KR20070015011A (ko) | 2007-02-01 |
| KR100824830B1 (ko) | 2008-04-23 |
| EP1748043B1 (fr) | 2008-08-20 |
| EA011126B1 (ru) | 2008-12-30 |
| SI1748043T1 (sl) | 2008-12-31 |
| DE602006002328D1 (de) | 2008-10-02 |
| EA200601248A1 (ru) | 2007-04-27 |
| PT1748043E (pt) | 2008-10-07 |
| CN1903843A (zh) | 2007-01-31 |
| AR054875A1 (es) | 2007-07-25 |
| AU2006203241A1 (en) | 2007-02-15 |
| MA28426B1 (fr) | 2007-02-01 |
| NZ548747A (en) | 2007-06-29 |
| MXPA06008415A (es) | 2007-01-29 |
| JP2007077135A (ja) | 2007-03-29 |
| NO20063461L (no) | 2007-01-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2036892T3 (da) | 1,2,4,5-tetrahydro-3H-benzazepinforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse | |
| DK1845978T3 (da) | Substituerede pyrazolopyridiner, sammensætninger, som indeholder disse, fremgangsmåde til fremstilling heraf, og anvendelse heraf | |
| DK1909764T3 (da) | Farmaceutisk sammensætninger omfattende levetiracetam og fremgangsmåde til deres fremstilling | |
| DK1720544T3 (da) | Nye azabicykliske derivater, fremstillingsmetode hertil og farmaceutiske sammensætninger indeholdende disse | |
| DK2107055T3 (da) | Dosmetinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse | |
| DK1490062T3 (da) | Glukokortikoidmimetika, fremgangsmåder til fremstilling deraf, farmaceutiske sammensætninger og anvendelser deraf | |
| IL185353A0 (en) | Azabicycloalkane derivatives , pharmaceutical compositions containing the same and methods for the preparation thereof | |
| IL193772A0 (en) | 4-oxoquinoline derivatives,methods for the preparation thereof and pharmaceutical compositions containing the same | |
| DK1939204T3 (da) | Kondenseret heterocyklisk derivat, medicinalsammensætning indeholdende samme og medicinsk anvendelse deraf | |
| DK1707564T3 (da) | Indanyl-piperazinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse | |
| NO20062605L (no) | Farmasoytisk formulering inneholdende smakssubstanser med forbedrede farmasoytiske egenskaper | |
| IL187534A0 (en) | Thiazole derivatives, use thereof and pharmaceutical compositions containing them | |
| DK1560826T3 (da) | Pyridopyrimidinonderivater, fremgangsmåde til fremstiling heraf og farmaceutiske sammensætninger indeholdende disse | |
| TWI315305B (en) | Piperidin-4-yl-amide derivatives,pharmaceutical compositions comprising the same,process for preparing the same and the use thereof | |
| DK1670769T3 (da) | Benzimidazol-derivater, sammensætninger indeholdende disse, fremstilling deraf og anvendelser deraf | |
| DK1558612T3 (da) | Imidazopyridinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse | |
| HUP0401522A2 (en) | New 4-benzylidene-piperidine derivatives, pharmaceutical compositions containing the same and process for their preparation | |
| ZA200902414B (en) | Indole derivatives, process for the preparation thereof and pharmaceutical compositions containing them | |
| HK1126190A1 (en) | Novel pyridinylaminoalkylene- and pyridinyloxyalkylene-cyclopropanamines, process for the preparation thereof and pharmaceutical compositions containing them | |
| DK1853220T3 (da) | Fremgangsmåde til fremstilling af tabletter indeholdende inflammationshæmmende non-steroid-lægemiddel, deres sammensætninger og medicinske anvendelse | |
| DK1748043T3 (da) | Polysubstituerede 1,1-pyridinyloxycyclopropanaminderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse | |
| DK1873140T3 (da) | Nye naphthalenderivater, fremgangsmåde til fremstillng heraf og famaceutiske sammensætninger indeholdende disse | |
| SI1906926T1 (sl) | Farmacevtski sestavek, ki obsega 2,3-dihidro-6-nitroimidazo(2,1-b)oksazolne derivate | |
| ATE416166T1 (de) | Novel polysubstituted 1,1- pyridinylaminocyclopropanamine derivatives, processes for their preparation and pharmaceutical composition containing them | |
| ZA200902413B (en) | Novel indole derivatives, process for the preparation thereof and pharmaceutical compositions containing them |